We are driven to make a difference to global health
P95 Julius Clinical is a global, science-led contract research organization (CRO) supporting clinical development from early-phase trials through late-phase and real-world evidence programs. The company specializes in complex research for biotech and pharmaceutical sponsors, with deep expertise across neuroscience, infectious diseases and vaccines, and cardiovascular, renal, and metabolic diseases. Backed by a leadership of scientific luminaries and more than 500 experts spanning five continents, P95 Julius Clinical combines the reach of a larger CRO with the agility of a mid-sized partner.
trusted by global organizations
our locations
We are headquartered in Belgium, with regional hubs on 5 continents, and offices in Austria, Colombia, Ghana, France, Kenya, Morocco, The Netherlands, South Africa, Thailand, and the USA. Our international team is based across over 50 countries.
our history
Learn more about our history and 25+ years of combined experience.
2011
- P95 was founded in 2011 in Leuven, Belgium, providing specialized consultancy services in pharmacovigilance and epidemiology
2015
- Established a data analytics center
2021
- Reacting to the challenges of the COVID-19 pandemic, P95 grew and expanded to new regions
- Acquired Pallas (Netherlands)
- First non-EU office (Colombia)
2023
- Became an Ampersand portfolio company
- First office in SE Asia (Thailand)
- Acquired OnQ Research enhancing portfolio with valuable clinical trial experience (South Africa)
2024
- First office in USA (North Carolina)
- Acquired 4Clinics (France) expanding clinical capabilities
- Acquired Assign DMB (Austria) expanding data management and biostatistics services
2025
- Formed strategic partnership with LatinaBA propelling vaccine research in Latin America
- Merged with Julius Clinical forming a global, science-led CRO delivering integrated clinical development and real-world evidence